Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zithromac Iv Special Investigation For Legionella Infection.

Trial Profile

Zithromac Iv Special Investigation For Legionella Infection.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Community-acquired pneumonia; Legionnaires' disease; Pelvic inflammatory disorders
  • Focus Adverse reactions
  • Acronyms RESCUE-L
  • Sponsors Pfizer

Most Recent Events

  • 09 Feb 2017 Status changed from active, no longer recruiting to completed.
  • 21 Nov 2016 Planned End Date changed from 1 Jan 2017 to 1 Dec 2016.
  • 09 Feb 2016 Planned End Date changed from 1 Feb 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top